News

We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take ...
In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing ...
Through the generous support of Regeneron, four times a year River Journal publishes the on-site report of a high school science student from the River Towns who is paired with a Regeneron […] ...
Regeneron Pharmaceuticals trades -30.18% away from its average analyst target price of $817.92 per share. The 24 analysts ...
The FDA does not plan a reorganization of the agency but will consolidate offices that handle travel and IT ...
Federal employee pension benefits are set to be pared back in Republicans’ giant tax and spending package working its way through the US House, another slap at a workforce roiled by Elon Musk ...
Regeneron Pharmaceuticals has a one year low of $525.99 and a one year high of $1,211.20. The firm has a market cap of $65.88 billion, a PE ratio of 15.74, a price-to-earnings-growth ratio of 2.34 ...
(CNN) — The American Federation of Government Employees is planning to lay off more than half its staff, as the largest federal employees’ union reels from President Donald Trump’s move to ...
That's why it's worth it to purchase Moderna's shares, as they're down by 36% this year. Regeneron Pharmaceuticals, a leading biotech company, faces some uncertainty. While its financial results ...
President Donald Trump issued an executive order on Thursday that will enable the government to fire probationary employees more easily. Instead of automatically gaining full status in one or two ...
Regeneron Pharmaceuticals has a 52-week low of $525.99 and a 52-week high of $1,211.20. The firm has a market capitalization of $65.57 billion, a PE ratio of 15.67, a price-to-earnings-growth ...
Sanofi signed a deal with Earendil Labs for $125 million upfront and $1.72 billion in milestone payments. Regeneron Pharmaceuticals signed a deal worth more than $3 billion with contract drug ...